EP4114390
Aðferðir til meðhöndlunar á Fabry-sjúkdómi í sjúklingum sem hafa stökkbreytingu í GLA-geninu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
5.3.2021EP published:
4.12.2024EP application number:
21715035.8
EP translation filed:
14.2.2025Grant published:
15.3.2025EPO information:
European Patent Register
Max expiry date:
4.3.2041Expiry date:
4.3.2027Next due date:
31.3.2027
Title in English:
METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING A MUTATION IN THE GLA GENELanguage of the patent:
English
Timeline
Today
5.3.2021EP application
4.12.2024EP Publication
14.2.2025Translation submitted
15.3.2025Registration published
4.3.2027Expires
Owner
Name:
Amicus Therapeutics, Inc.Address:
3675 Market Street, Philadelphia, PA 19104, US
Inventor
Name:
BENJAMIN, ElfridaAddress:
Philadelpha, Pennsylvania 19104, US
Name:
WU, XiaoyangAddress:
Philadelpha, Pennsylvania 19104, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
202062986297 PDate:
6.3.2020Country:
US
Classification
Categories:
A61K 31/445, A61P 3/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 7.2.2025
Expires: 4.3.2026
Payer: Árnason Faktor ehf.
Number: 6
Paid: 5.3.2026
Expires: 4.3.2027
Payer: Árnason Faktor ehf.